Trial Identifier: | ACE-LY-106 |
Sponsor: | AcertaPharma |
Collaborator: | AstraZeneca |
NCTID: | NCT02717624 |
Start Date: | May 2016 |
Primary Completion Date: | March 2026 |
Study Completion Date: | March 2026 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
United States of America, IL | Chicago, IL, United States of America, 60612 |
United States of America, IL | Skokie, IL, United States of America, 60077 |
United States of America, OH | Columbus, OH, United States of America, 43210 |
United States of America, TN | Nashville, TN, United States of America, 37203 |
United States of America, WA | Seattle, WA, United States of America, 98109 |
United States of America, WA | Seattle, WA, United States of America, 98122 |
Poland | Krakow, Poland, 30-510 |
Poland | Lodz, Poland, 93-510 |
Poland | Olsztyn, Poland, 10-228 |
Poland | Warszawa, Poland, 02-106 |
United States of America, KY | Louisville, KY, United States of America, 40207 |
United States of America, New York | Lake Success, New York, United States of America, 11042 |
Italy | Bologna, Italy, 40138 |
Italy | Turin, Italy, 10126 |
United States of America, MI | Ann Arbor, MI, United States of America, 48109 |
United States of America, TX | Houston, TX, United States of America, 77030 |
United States of America, NJ | Hackensack, NJ, United States of America, 07601 |
United States of America, NJ | Morristown, NJ, United States of America, 07960 |
United States of America, CA | Downey, CA, United States of America, 90241 |